Liver transplantation for fulminant hepatitis related to nevirapine therapy

被引：10

作者：

Buyse, Sophie

Vibert, Eric

Sebagh, Mylene

Antonini, Teresa

Ichai, Philippe

Castaing, Denis

Samuel, Didier

Duclos-Vallee, Jean-Charles

机构：

[1] Hop Paul Brousse, Ctr Hepatobiliaire, Dept Pathol, F-94800 Villejuif, France

[2] Hop Paul Brousse, INSERM, U785, F-94800 Villejuif, France

[3] Hop Paul Brousse, Dept Hepatol & Hepatobiliar Surg, F-94800 Villejuif, France

来源：

LIVER TRANSPLANTATION | 2006年 / 12卷 / 12期

关键词：

D O I：

10.1002/lt.20985

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Drug-induced hepatotoxicity is an important cause of hepatocellular injury. Non-nucleoside retroviral transcriptase inhibitors are known to cause hepatotoxicity. We describe a detailed case of fulminant hepatitis induced by nevirapine (Viramune) and treated by liver transplantation.

引用

收藏

页码：1880 / 1882

页数：3

相关论文

共 11 条

[1] Chronic hepatotoxicity after long-term antiretroviral treatment including nevirapine [J].

de Maat, MMR ;

Beijnen, JH ;

Schellens, JHM ;

Mulder, JW .

JOURNAL OF INFECTION, 2005, 50 (03) :262-264

[2] Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors [J].

Dieterich, DT ;

Robinson, PA ;

Love, J ;

Stern, JO .

CLINICAL INFECTIOUS DISEASES, 2004, 38 :S80-S89

[3] Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy [J].

Haugaard, SB ;

Andersen, O ;

Pedersen, SB ;

Dela, F ;

Richelsen, B ;

Nielsen, JO ;

Madsbad, S ;

Iversen, J .

JOURNAL OF MEDICAL VIROLOGY, 2005, 77 (01) :29-38

[4] Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: A case report [J].

Jain, AKB ;

Venkataramanan, R ;

Fridell, JA ;

Gadomski, M ;

Shaw, LM ;

Ragni, M ;

Korecka, M ;

Fung, J .

LIVER TRANSPLANTATION, 2002, 8 (09) :838-840

[5] Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts [J].

Martin, AM ;

Nolan, D ;

James, I ;

Cameron, P ;

Keller, J ;

Moore, C ;

Phillips, E ;

Christiansen, FT ;

Mallal, S .

AIDS, 2005, 19 (01) :97-99

[6] Hepatotoxicity of antiretrovirals:: Incidence, mechanisms and management [J].

Núñez, M .

JOURNAL OF HEPATOLOGY, 2006, 44 :S132-S139

[7] Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals [J].

Patel, SM ;

Johnson, S ;

Belknap, SM ;

Chan, J ;

Sha, BE ;

Bennett, C .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (02) :120-125

[8]

Piliero P J, 2001, AIDS Read, V11, P379

[9]

Sha BE, 2000, JAMA-J AM MED ASSOC, V284, P2723

[10] A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients [J].

Stern, JO ;

Robinson, PA ;

Love, J ;

Lanes, S ;

Imperiale, MS ;

Mayers, DL .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 :S21-S33